NK cell therapy is fast developing into a busy field, so it's something of a coup for Shoreline to forge an alliance with an established player like Gilead/Kite.

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...

Prof. MENG Guangxun's team from the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences, and collaborators, have revealed a novel mechanism whereby a short form of IL-18, ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 15.00%, which has investors questioning if this is right time ...

bringing down the cost of CAR therapy to one per cent of where it is now, which is why we are so very excited about this.” Aside from the CD19 targeting component, Rezvani’s NK cells express a ...

NK Cells Expressing Interleukin-21 Show Promising ... laying the groundwork for more effective treatment of brain tumors and other ... Researchers Develop Promising Therapy Treatment That Can ...